Pattern Genomics LLC, a Madison, Conn.-based developer of a novel software platform, called Daydreamer, that will enable simultaneous pattern analysis of DNA sequences and molecular assay design based on large-scale DNA sequencing data, raised $150k in funding.
The backer was Connecticut Innovations, which was joined by an individual investor.
The company’s software aims to substantially reduce the time and cost of assay development by replacing ad hoc research with a general assay design process based on proprietary bioinformatics.
Pattern Genomics will offer an assay design service to the diagnostics and pharmaceutical industry, CLIA laboratories, governments and foundations.
FinSMEs
21/03/2013